The
National Cervical Cancer Elimination Action Plan
2025 - 2030

-->

Key Result Areas, Targets & Objectives

HPV vaccination coverage among eligible girls is increased to at least 90%.

HPV Vaccination

Operational Objectives

• Expand equitable, timely, and integrated HPV vaccine delivery

• Strengthen HPV vaccination workforce capacity

• Strengthen HPV vaccination data systems

• Strengthen HPV vaccine supply chains

• Secure sustainable HPV vaccine financing

• Promote political leadership and multisectoral coordination to support HPV vaccination.

• Promote behavior change communication for HPV vaccine uptake.

90%

of Girls Fully Vaccinated Against HIV by 15 Years

70%

of Women are Screened with High Performance Tests by 35 and 45 Years

90%

of Women Identified Receive Treatment for Pre-Concievable

At least 70% of women 30-49 years are screened using HPV testing; and at least 90% of those with precancer receive treatment

Screening and Pre-Cancer Treatment

Operational Objectives

• Ensure facility readiness for screening and precancer treatment.

• Ensure quality assurance in cervical cancer screening.

• Strengthen health worker cervical cancer screening.

• Increase community awareness and screening demand

• Improve data use for decision-making

• Prioritize financing for cervical cancer screening and treatment

• Strengthen leadership and governance for the cervical cancer screening program

• Ensure provision of quality screening and precancer treatment services.

90%

of Girls Fully Vaccinated Against HIV by 15 Years

70%

of Women are Screened with High Performance Tests by 35 and 45 Years

90%

of Women Identified Receive Treatment for Pre-Concievable

At least 90% of women with invasive cervical cancer receive comprehensive treatment, palliative and survivorship care.

Diagnosis, Treatment, Palliative and Survivorship Care for Invasive Cervical Cancer

Operational Objectives

• Strengthen infrastructure for cervical cancer diagnosis and treatment.

• Expand skilled multidisciplinary oncology workforce.

• Ensure availability of cervical cancer diagnosis and treatment technologies/supplies

• Provide comprehensive financial coverage for cervical cancer diagnosis and treatment

• Strengthen data systems for cervical cancer diagnosis and treatment.

• Strengthen leadership and governance for diagnosis and treatment.

90%

of Girls Fully Vaccinated Against HIV by 15 Years

70%

of Women are Screened with High Performance Tests by 35 and 45 Years

90%

of Women Identified Receive Treatment for Pre-Concievable